Skip to main content
. Author manuscript; available in PMC: 2017 Oct 5.
Published in final edited form as: Leuk Res. 2014 Sep 16;38(11):1350–1357. doi: 10.1016/j.leukres.2014.09.002

Fig. 5.

Fig. 5

Co-treatment of simvastatin and tipifarnib blocks ERK phosphorylation in human leukemia cells. Upon treatment with simvastatin (4 μM) and tipifarnib (1 μM), alone and in combination for 24hr, leukemia cells were processed for western blot analysis using the indicated antibodies. GAPDH was used as a loading control. SIM, simvastatin. TIP, tipifarnib.